Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126098321 | 12609832 | 1 | I | 20160621 | 20160718 | 20160801 | 20160801 | EXP | DE-LUPIN PHARMACEUTICALS INC.-E2B_00005883 | LUPIN | 72.00 | YR | F | Y | 61.00000 | KG | 20160801 | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126098321 | 12609832 | 1 | SS | Adenuric | FEBUXOSTAT | 1 | Unknown | UNKNOWN | 0 | 80 | MG | QD | |||||||
| 126098321 | 12609832 | 2 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | UNKNOWN | 78103 | 80 | MG | QD | |||||||
| 126098321 | 12609832 | 3 | C | Valsacor 320/25 mg | 2 | Oral | 0 | 1 | DF | QD | |||||||||
| 126098321 | 12609832 | 4 | C | RANEXA | RANOLAZINE | 1 | Oral | 0 | 375 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126098321 | 12609832 | 1 | Hyperuricaemia |
| 126098321 | 12609832 | 2 | Hyperlipidaemia |
| 126098321 | 12609832 | 3 | Hypertension |
| 126098321 | 12609832 | 4 | Arrhythmia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126098321 | 12609832 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126098321 | 12609832 | Hypoaesthesia | |
| 126098321 | 12609832 | Myopathy | |
| 126098321 | 12609832 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |